New pharmacological tool approved for opioid addiction.
Sansovich
Danny
D
HIV Outpatient Program, Medical Center of Louisiana at New Orleans, USA.
D002047:Buprenorphine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D006801:Humans; D009270:Naloxone / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D009293:Opioid-Related Disorders / Q000188:drug therapy / Q000534:rehabilitation*
D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine